Download as PDF

Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

First Session, Forty-first Parliament, 2011-12


Wednesday, March 28, 2012
Thursday, March 29, 2012

Issue No. 13

Second and third meetings on:

Study on prescription pharmaceuticals in Canada


Wednesday, March 28, 2012

Health Canada:

Paul Glover, Assistant Deputy Minister, Health Products and Food Branch (HPFB);

Barbara Sabourin, Director General, Therapeutic Products Directorate, Health Products and Food Branch (HPFB);

Dr. Robert Cushman, Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch (HPFB).

Thursday, March 29, 2012

Canadian Institutes of Health Research:

Dr. Alain Beaudet, President.

Drug Safety and Effectiveness Network:

Dr. Robert Peterson, Executive Director.

Health Canada:

Barbara Sabourin, Director General, Helth Products and Food Banch, Therapeutic Products Directorate (TPD);

Dr. John Patrick Stewart, A/Director General, Clinical Trials Office, Therapeutic Products Directorate (TPD);

Kimby Barton, Director, Bureau of Cardiology, Allergy and Neurological Sciences, Therapeutic Products Directorate (TPD).


The Honourable Kelvin Kenneth Ogilvie, Chair

The Honourable Art Eggleton, P.C., Deputy Chair


The Honourable Senators:

Callbeck, Champagne, P.C., *Cowan (or Tardif), Demers, Dyck, *LeBreton, P.C. (or Carignan), Martin, Merchant, Seidman, Seth, Verner, P.C.

*Ex officio members

(Quorum 4)

Changes in membership of the committee:

Pursuant to rule 85(4), membership of the committee was amended as follows:

The Honourable Senator Martin replaced the Honourable Senator Plett (March 29, 2012).

The Honourable Senator Campbell replaced the Honourable Senator Peterson (March 28, 2012).

The Honourable Senator Peterson replaced the Honourable Senator Cordy (March 28, 2012).

The Honourable Senator Plett replaced the Honourable Senator Martin (March 27, 2012).